AI Article Synopsis
- The article reviews how to diagnose and assess risks associated with smoldering myeloma (SMM), focusing on practical management strategies for clinicians.
- It discusses recent studies (ECOG E3A06 and GEM-CESAR) that highlight the benefits of early treatment for high-risk SMM patients, emphasizing the real-world implications of these findings.
- The conclusions point out that the methods for risk assessment and standard treatment for SMM are changing, and the article offers updates on clinical data and management recommendations.
Article Abstract
Purpose Of Review: The aim of this article is to review the diagnosis and risk stratification of smoldering myeloma (SMM), describe recently published data regarding the early treatment of SMM, and to provide practical strategies on how to manage patients with SMM in the clinic.
Recent Findings: Recently published data from the ECOG E3A06 and GEM-CESAR studies supporting early intervention for certain subsets of high-risk SMM patients will be presented, and the relevance of these findings in relation to real-life application will be explored.
Summary: Accurate risk-stratification and standard of care for SMM is evolving, and here we summarize the pertinent clinical data and provide recommendations for clinical management of SMM patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/CCO.0000000000000676 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!